Literature DB >> 32984897

Serial troponin measurements to monitor risk and response to endothelin A antagonism in chronic kidney disease.

Atul Anand1, Tariq E Farrah1,2, Eve Miller-Hodges1,2, Anoop S V Shah1, Fiona E Strachan1, Edwin Carter1, Neil R Johnston1, David J Webb1, Nicholas L Mills1, Neeraj Dhaun1,2.   

Abstract

Entities:  

Year:  2021        PMID： 32984897      PMCID： PMC7834594          DOI： 10.1093/ndt/gfaa214

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  12 in total

1.  High-Sensitivity Cardiac Troponin T and Risk of Hypertension.

Authors:  John W McEvoy; Yuan Chen; Vijay Nambi; Christie M Ballantyne; A Richey Sharrett; Lawrence J Appel; Wendy S Post; Roger S Blumenthal; Kunihiro Matsushita; Elizabeth Selvin
Journal:  Circulation       Date:  2015-07-07       Impact factor: 29.690

2.  Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.

Authors:  Neeraj Dhaun; Iain M MacIntyre; Debbie Kerr; Vanessa Melville; Neil R Johnston; Scott Haughie; Jane Goddard; David J Webb
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

3.  Control of hypertension in adults with chronic kidney disease in the United States.

Authors:  Carmen A Peralta; Leroi S Hicks; Glenn M Chertow; John Z Ayanian; Eric Vittinghoff; Feng Lin; Michael G Shlipak
Journal:  Hypertension       Date:  2005-04-25       Impact factor: 10.190

4.  Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Authors:  Hiddo J L Heerspink; Hans-Henrik Parving; Dennis L Andress; George Bakris; Ricardo Correa-Rotter; Fan-Fan Hou; Dalane W Kitzman; Donald Kohan; Hirofumi Makino; John J V McMurray; Joel Z Melnick; Michael G Miller; Pablo E Pergola; Vlado Perkovic; Sheldon Tobe; Tingting Yi; Melissa Wigderson; Dick de Zeeuw
Journal:  Lancet       Date:  2019-04-14       Impact factor: 79.321

Review 5.  Endothelins in cardiovascular biology and therapeutics.

Authors:  Neeraj Dhaun; David J Webb
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

6.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

7.  High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.

Authors:  Ian Ford; Anoop S V Shah; Ruiqi Zhang; David A McAllister; Fiona E Strachan; Muriel Caslake; David E Newby; Chris J Packard; Nicholas L Mills
Journal:  J Am Coll Cardiol       Date:  2016-12-27       Impact factor: 24.094

Review 8.  High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants.

Authors:  Peter Willeit; Paul Welsh; Jonathan D W Evans; Lena Tschiderer; Charles Boachie; J Wouter Jukema; Ian Ford; Stella Trompet; David J Stott; Patricia M Kearney; Simon P Mooijaart; Stefan Kiechl; Emanuele Di Angelantonio; Naveed Sattar
Journal:  J Am Coll Cardiol       Date:  2017-08-01       Impact factor: 24.094

9.  Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2020-02-13       Impact factor: 79.321

10.  High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study.

Authors:  Anoop S V Shah; Atul Anand; Yader Sandoval; Kuan Ken Lee; Stephen W Smith; Philip D Adamson; Andrew R Chapman; Timothy Langdon; Dennis Sandeman; Amar Vaswani; Fiona E Strachan; Amy Ferry; Alexandra G Stirzaker; Alan Reid; Alasdair J Gray; Paul O Collinson; David A McAllister; Fred S Apple; David E Newby; Nicholas L Mills
Journal:  Lancet       Date:  2015-10-08       Impact factor: 202.731
View more
  1 in total

Review 1.  Applications of cardiac biomarkers in chronic kidney disease.

Authors:  Alexander Kula; Nisha Bansal
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-08-04       Impact factor: 3.416
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.